| Gwendolyn Leigh Colyer, CRNA | |
|
5901 Monclova Rd, Maumee, OH 43537-1855 | |
| (419) 897-8370 | |
| Not Available |
| Full Name | Gwendolyn Leigh Colyer |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 5901 Monclova Rd, Maumee, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063485241 | NPI | - | NPPES |
| 2559299 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | COA.08219-NA (Missouri) | Primary |
| Entity Name | Promedica Central Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043270150 PECOS PAC ID: 2365348190 Enrollment ID: O20031211000226 |
News Archive
A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy.
UCSF scientists are reporting several studies showing that psychological stress leads to shorter telomeres - the protective caps on the ends of chromosomes that are a measure of cell age and, thus, health. The findings also suggest that exercise may prevent this damage.
The Department of Justice announced today that it will not challenge a proposal by Memorial Health Inc. (Memorial), and St. Joseph's/Candler Health System (St. Joseph's/Candler) to enter an exclusive joint purchasing agreement with respect to the purchase of certain medical and surgical supplies.
Exelixis, Inc. today reported positive updated interim data from the cohort of hepatocellular carcinoma (HCC) patients participating in the ongoing phase 2 randomized discontinuation trial (RDT) of cabozantinib.
› Verified 7 days ago
| Entity Name | Southwest Anesthesia Services Psc, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188129 PECOS PAC ID: 3779483631 Enrollment ID: O20040109000000 |
News Archive
A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy.
UCSF scientists are reporting several studies showing that psychological stress leads to shorter telomeres - the protective caps on the ends of chromosomes that are a measure of cell age and, thus, health. The findings also suggest that exercise may prevent this damage.
The Department of Justice announced today that it will not challenge a proposal by Memorial Health Inc. (Memorial), and St. Joseph's/Candler Health System (St. Joseph's/Candler) to enter an exclusive joint purchasing agreement with respect to the purchase of certain medical and surgical supplies.
Exelixis, Inc. today reported positive updated interim data from the cohort of hepatocellular carcinoma (HCC) patients participating in the ongoing phase 2 randomized discontinuation trial (RDT) of cabozantinib.
› Verified 7 days ago
| Entity Name | Ohio Anesthesia Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639348113 PECOS PAC ID: 9537222138 Enrollment ID: O20090108000069 |
News Archive
A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy.
UCSF scientists are reporting several studies showing that psychological stress leads to shorter telomeres - the protective caps on the ends of chromosomes that are a measure of cell age and, thus, health. The findings also suggest that exercise may prevent this damage.
The Department of Justice announced today that it will not challenge a proposal by Memorial Health Inc. (Memorial), and St. Joseph's/Candler Health System (St. Joseph's/Candler) to enter an exclusive joint purchasing agreement with respect to the purchase of certain medical and surgical supplies.
Exelixis, Inc. today reported positive updated interim data from the cohort of hepatocellular carcinoma (HCC) patients participating in the ongoing phase 2 randomized discontinuation trial (RDT) of cabozantinib.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gwendolyn Leigh Colyer, CRNA 2749 Pin Oak Dr, Toledo, OH 43615-1862 Ph: (419) 841-0659 | Gwendolyn Leigh Colyer, CRNA 5901 Monclova Rd, Maumee, OH 43537-1855 Ph: (419) 897-8370 |
News Archive
A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy.
UCSF scientists are reporting several studies showing that psychological stress leads to shorter telomeres - the protective caps on the ends of chromosomes that are a measure of cell age and, thus, health. The findings also suggest that exercise may prevent this damage.
The Department of Justice announced today that it will not challenge a proposal by Memorial Health Inc. (Memorial), and St. Joseph's/Candler Health System (St. Joseph's/Candler) to enter an exclusive joint purchasing agreement with respect to the purchase of certain medical and surgical supplies.
Exelixis, Inc. today reported positive updated interim data from the cohort of hepatocellular carcinoma (HCC) patients participating in the ongoing phase 2 randomized discontinuation trial (RDT) of cabozantinib.
› Verified 7 days ago
James C. Padgett, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5901 Monclova Rd, Maumee, OH 43537 Phone: 419-897-8370 | |
Marcia K Carroll, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 5901 Monclova Rd, Maumee, OH 43537 Phone: 419-897-8370 | |
William Albert Schwartz, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5901 Monclova Rd, Maumee, OH 43537 Phone: 419-897-8370 | |
Angela J. White, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 5901 Monclova Rd, Maumee, OH 43537 Phone: 419-897-8370 Fax: 419-897-8379 | |
Joanne Elaine Rush, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5901 Monclova Rd, Maumee, OH 43537 Phone: 419-897-8370 | |
Mary M. Turnbell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5901 Monclova Rd, Maumee, OH 43537 Phone: 419-897-8370 |